Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/9/2025

Management of Local Reactions to Topical Chemotherapy

Understanding Expected vs. Problematic Reactions

  • Local skin reactions to topical chemotherapy are expected and indicate treatment efficacy, not treatment failure, according to the British Journal of Dermatology 1

Grade-Based Treatment Algorithm

  • For mild reactions, the British Journal of Dermatology recommends continuing treatment at the current dose, applying emollients liberally, and using topical moderate-potency corticosteroids for symptomatic relief 1, 2, 3
  • For moderate reactions, the Annals of Oncology suggests continuing treatment at the current dose, applying skin-type-adjusted moisturizers, and using topical moderate-to-high potency steroids, as well as oral antihistamines for pruritus 1, 2, 3, 4, 5
  • For severe reactions or intolerable Grade 2 reactions, the Annals of Oncology recommends interrupting treatment until reactions improve, continuing aggressive symptomatic management, and considering short-term oral systemic corticosteroids 1, 2, 3, 4

Specific Symptom Management

  • For dry skin, the Annals of Oncology suggests using soap-free shower gel and bath oils, avoiding hot showers and excessive soap use, and applying urea- or glycerin-based moisturizers at least once daily 2, 4, 6
  • For pruritus, the Annals of Oncology recommends applying urea- or polidocanol-containing lotions, using topical corticosteroids for inflammatory components, and administering oral H1-antihistamines 2, 3, 4, 5

Critical Pitfalls to Avoid

  • The Journal of Allergy and Clinical Immunology advises against prescribing antibiotics for inflammatory reactions unless there is clear evidence of secondary infection 7

When to Refer

  • Consider dermatology referral if reactions worsen despite appropriate management after 2 weeks, if Grade 3-4 reactions develop, or if systemic symptoms emerge, according to the Annals of Oncology 2, 4